Unimpaired Skin Carcinogenesis in Desmoglein 3 Knockout Mice

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Baron, Sylvain ^a   Hoang, Anabel ^a   Vogel, Hannes ^a   Attardi, Laura D ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DESMOGLEIN 3; GLYCOPROTEIN; PERP PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PROTEIN FUNCTION; SKIN CANCER; SKIN CARCINOGENESIS; TUMOR GROWTH; TUMOR PROMOTION; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; CELL ADHESION; CELL TRANSFORMATION, NEOPLASTIC; DESMOGLEIN 3; DESMOSOMES; KERATINOCYTES; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

MUS;

EID: 84869784358     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050024     Document Type: Article

References (43)

1. Green KJ, Gaudry CA, (2000) Are desmosomes more than tethers for intermediate filaments? Nature reviews Molecular cell biology 1: 208-216.
2. Kobielak A, Fuchs E, (2004) Alpha-catenin: at the junction of intercellular adhesion and actin dynamics. Nature reviews Molecular cell biology 5: 614-625.
3. Yin T, Green KJ, (2004) Regulation of desmosome assembly and adhesion. Seminars in cell & developmental biology 15: 665-677.
4. Chen CP, Posy S, Ben-Shaul A, Shapiro L, Honig BH, (2005) Specificity of cell-cell adhesion by classical cadherins: Critical role for low-affinity dimerization through beta-strand swapping. Proceedings of the National Academy of Sciences of the United States of America 102: 8531-8536.
5. Nose A, Tsuji K, Takeichi M, (1990) Localization of specificity determining sites in cadherin cell adhesion molecules. Cell 61: 147-155.
6. Pertz O, Bozic D, Koch AW, Fauser C, Brancaccio A, et al. (1999) A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. The EMBO journal 18: 1738-1747.
7. Yap AS, Brieher WM, Gumbiner BM, (1997) Molecular and functional analysis of cadherin-based adherens junctions. Annual review of cell and developmental biology 13: 119-146.
8. Chitaev NA, Troyanovsky SM, (1997) Direct Ca2+-dependent heterophilic interaction between desmosomal cadherins, desmoglein and desmocollin, contributes to cell-cell adhesion. The Journal of cell biology 138: 193-201.
9. Nie Z, Merritt A, Rouhi-Parkouhi M, Tabernero L, Garrod D, (2011) Membrane-impermeable cross-linking provides evidence for homophilic, isoform-specific binding of desmosomal cadherins in epithelial cells. The Journal of biological chemistry 286: 2143-2154.
10. Ihrie RA, Marques MR, Nguyen BT, Horner JS, Papazoglu C, et al. (2005) Perp is a p63-regulated gene essential for epithelial integrity. Cell 120: 843-856.
11. Berx G, Becker KF, Hofler H, van Roy F, (1998) Mutations of the human E-cadherin (CDH1) gene. Human mutation 12: 226-237.
12. Bremnes RM, Veve R, Gabrielson E, Hirsch FR, Baron A, et al. (2002) High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 20: 2417-2428.
13. Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO, (2005) E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Histopathology 46: 685-693.
14. Syrigos KN, Krausz T, Waxman J, Pandha H, Rowlinson-Busza G, et al. (1995) E-cadherin expression in bladder cancer using formalin-fixed, paraffin-embedded tissues: correlation with histopathological grade, tumour stage and survival. International journal of cancer Journal international du cancer 64: 367-370.
15. Wijnhoven BP, Pignatelli M, Dinjens WN, Tilanus HW, (2005) Reduced p120ctn expression correlates with poor survival in patients with adenocarcinoma of the gastroesophageal junction. Journal of surgical oncology 92: 116-123.
16. Zheng Z, Pan J, Chu B, Wong YC, Cheung AL, et al. (1999) Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Human pathology 30: 458-466.
17. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G, (1998) A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392: 190-193.
18. Derksen PW, Liu X, Saridin F, van der Gulden H, Zevenhoven J, et al. (2006) Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer cell 10: 437-449.
19. Tada H, Hatoko M, Tanaka A, Kuwahara M, Muramatsu T, (2000) Expression of desmoglein I and plakoglobin in skin carcinomas. Journal of cutaneous pathology 27: 24-29.
20. Wong MP, Cheang M, Yorida E, Coldman A, Gilks CB, et al. (2008) Loss of desmoglein 1 expression associated with worse prognosis in head and neck squamous cell carcinoma patients. Pathology 40: 611-616.
21. Wang L, Liu T, Wang Y, Cao L, Nishioka M, et al. (2007) Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation. Virchows Arch 451: 959-966.
22. Oshiro MM, Kim CJ, Wozniak RJ, Junk DJ, Munoz-Rodriguez JL, et al. (2005) Epigenetic silencing of DSC3 is a common event in human breast cancer. Breast cancer research: BCR 7: R669-680.
23. Brennan D, Mahoney MG, (2009) Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study. Cell adhesion & migration 3: 148-154.
24. Brennan D, Hu Y, Joubeh S, Choi YW, Whitaker-Menezes D, et al. (2007) Suprabasal Dsg2 expression in transgenic mouse skin confers a hyperproliferative and apoptosis-resistant phenotype to keratinocytes. J Cell Sci 120: 758-771.
25. Huang CC, Lee TJ, Chang PH, Lee YS, Chuang CC, et al. (2010) Desmoglein 3 is overexpressed in inverted papilloma and squamous cell carcinoma of sinonasal cavity. Laryngoscope 120: 26-29.
26. Chen YJ, Chang JT, Lee L, Wang HM, Liao CT, et al. (2007) DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis. Oncogene 26: 467-476.
27. Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, et al. (2009) The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am J Pathol 174: 1629-1637.
28. Mannan T, Jing S, Foroushania SH, Fortune F, Wan H, (2011) RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation. Cell proliferation 44: 301-310.
29. Beaudry VG, Jiang D, Dusek RL, Park EJ, Knezevich S, et al. (2010) Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis. PLoS genetics 6: e1001168.
30. Huen AC, Park JK, Godsel LM, Chen X, Bannon LJ, et al. (2002) Intermediate filament-membrane attachments function synergistically with actin-dependent contacts to regulate intercellular adhesive strength. The Journal of cell biology 159: 1005-1017.
31. South AP, Wan H, Stone MG, Dopping-Hepenstal PJ, Purkis PE, et al. (2003) Lack of plakophilin 1 increases keratinocyte migration and reduces desmosome stability. Journal of cell science 116: 3303-3314.
32. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, et al. (1997) Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 137: 1091-1102.
33. Koch PJ, Mahoney MG, Cotsarelis G, Rothenberger K, Lavker RM, et al. (1998) Desmoglein 3 anchors telogen hair in the follicle. J Cell Sci 111 (Pt 17): 2529-2537.
34. Pierceall WE, Goldberg LH, Tainsky MA, Mukhopadhyay T, Ananthaswamy HN, (1991) Ras gene mutation and amplification in human nonmelanoma skin cancers. Molecular carcinogenesis 4: 196-202.
35. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America 88: 10124-10128.
36. Kanjilal S, Pierceall WE, Cummings KK, Kripke ML, Ananthaswamy HN, (1993) High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer research 53: 2961-2964.
37. Jiang W, Ananthaswamy HN, Muller HK, Kripke ML, (1999) p53 protects against skin cancer induction by UV-B radiation. Oncogene 18: 4247-4253.
38. Dusek RL, Getsios S, Chen F, Park JK, Amargo EV, et al. (2006) The differentiation-dependent desmosomal cadherin desmoglein 1 is a novel caspase-3 target that regulates apoptosis in keratinocytes. J Biol Chem 281: 3614-3624.
39. Garrod DR, Merritt AJ, Nie Z, (2002) Desmosomal cadherins. Current opinion in cell biology 14: 537-545.
40. Marques MR, Horner JS, Ihrie RA, Bronson RT, Attardi LD, (2005) Mice lacking the p53/p63 target gene Perp are resistant to papilloma development. Cancer research 65: 6551-6556.
41. Robanus-Maandag E, Dekker M, van der Valk M, Carrozza ML, Jeanny JC, et al. (1998) p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes & development 12: 1599-1609.
42. Hanakawa Y, Matsuyoshi N, Stanley JR, (2002) Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion. The Journal of investigative dermatology 119: 27-31.
43. Chen J, O'Shea C, Fitzpatrick JE, Koster MI, Koch PJ, (2011) Loss of desmocollin 3 in skin tumor development and progression. Molecular carcinogenesis 51(7): 535-45.